BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14587005)

  • 1. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues.
    Swanson MG; Vigneron DB; Tabatabai ZL; Males RG; Schmitt L; Carroll PR; James JK; Hurd RE; Kurhanewicz J
    Magn Reson Med; 2003 Nov; 50(5):944-54. PubMed ID: 14587005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
    Swanson MG; Zektzer AS; Tabatabai ZL; Simko J; Jarso S; Keshari KR; Schmitt L; Carroll PR; Shinohara K; Vigneron DB; Kurhanewicz J
    Magn Reson Med; 2006 Jun; 55(6):1257-64. PubMed ID: 16685733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.
    Kurhanewicz J; Swanson MG; Nelson SJ; Vigneron DB
    J Magn Reson Imaging; 2002 Oct; 16(4):451-63. PubMed ID: 12353259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
    Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
    NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis].
    Gao XX; Xu YZ; Zhao MX; Qi J; Li HZ; Wu JG
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1942-50. PubMed ID: 18975839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1H magnetic resonance spectroscopy of the prostate].
    Mueller-Lisse UG; Scherr M
    Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
    Selnaes KM; Gribbestad IS; Bertilsson H; Wright A; Angelsen A; Heerschap A; Tessem MB
    NMR Biomed; 2013 May; 26(5):600-6. PubMed ID: 23280546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional MR spectroscopic imaging of prostate cancer in vivo.
    Thomas MA; Nagarajan R; Huda A; Margolis D; Sarma MK; Sheng K; Reiter RE; Raman SS
    NMR Biomed; 2014 Jan; 27(1):53-66. PubMed ID: 23904127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.
    Lagemaat MW; Vos EK; Maas MC; Bitz AK; Orzada S; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
    Invest Radiol; 2014 May; 49(5):363-72. PubMed ID: 24335715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
    Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
    NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
    Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
    NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.
    Mueller-Lisse UG; Swanson MG; Vigneron DB; Hricak H; Bessette A; Males RG; Wood PJ; Noworolski S; Nelson SJ; Barken I; Carroll PR; Kurhanewicz J
    Magn Reson Med; 2001 Jul; 46(1):49-57. PubMed ID: 11443710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies.
    Mirnezami R; Jiménez B; Li JV; Kinross JM; Veselkov K; Goldin RD; Holmes E; Nicholson JK; Darzi A
    Ann Surg; 2014 Jun; 259(6):1138-49. PubMed ID: 23860197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.
    Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P
    Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.